These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 17194992)

  • 1. [Osteonecrosis of the jaws associated with bisphosphonates: five cases].
    Woeller A; Gering A; Brix M; Bettega G; Lebeau J
    Rev Stomatol Chir Maxillofac; 2006 Dec; 107(6):417-22. PubMed ID: 17194992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bisphosphonates and maxillo-mandibular osteo(chemo)necrosis].
    Magremanne M; Vervaet C; Dufrasne L; Declercq I; Legrand W; Daelemans P
    Rev Stomatol Chir Maxillofac; 2006 Dec; 107(6):423-8. PubMed ID: 17194993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteonecrosis of the jaws and bisphosphonate treatment in cancer patients.
    Wutzl A; Eisenmenger G; Hoffmann M; Czerny C; Moser D; Pietschmann P; Ewers R; Baumann A
    Wien Klin Wochenschr; 2006 Aug; 118(15-16):473-8. PubMed ID: 16957978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphosphonate-associated osteonecrosis of the jaws: a therapeutic dilemma.
    Diego R; D'Orto O; Pagani D; Agazzi A; Marzano U; Derada Troletti G; Fontanella W; Pignataro L
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):e1-5. PubMed ID: 17197204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisphosphonate-induced avascular osteonecrosis of the jaws: a clinical report of 11 cases.
    Dimitrakopoulos I; Magopoulos C; Karakasis D
    Int J Oral Maxillofac Surg; 2006 Jul; 35(7):588-93. PubMed ID: 16687238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone necrosis of the jaws associated with bisphosphonate treatment: a report of twenty-nine cases.
    Merigo E; Manfredi M; Meleti M; Guidotti R; Ripasarti A; Zanzucchi E; D'Aleo P; Corradi D; Corcione L; Sesenna E; Ferrari S; Poli T; Bonaninil M; Vescovi P
    Acta Biomed; 2006 Aug; 77(2):109-17. PubMed ID: 17172192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Why osteonecrosis of the jaw after bisphosphonates treatment is more frequent in multiple myeloma than in solid tumors.
    Delibasi T; Altundag K; Kanlioglu Y
    J Oral Maxillofac Surg; 2006 Jun; 64(6):995-6. PubMed ID: 16713825
    [No Abstract]   [Full Text] [Related]  

  • 8. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment.
    Marx RE; Sawatari Y; Fortin M; Broumand V
    J Oral Maxillofac Surg; 2005 Nov; 63(11):1567-75. PubMed ID: 16243172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteonecrosis of the jaws in patients with bone metastasis receiving intravenous bisphosphonates. A rising concern.
    Aguiar Bujanda D; Cabrera Suárez MA; Bohn Sarmiento U; Quintero Pérez S; Aguiar Morales J
    Clin Transl Oncol; 2006 Dec; 8(12):919-21. PubMed ID: 17169767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bisphosphonates-associated osteonecrosis of the jaw: review on reported cases].
    Gering A; Grange L; Villier C; Woeller A; Mallaret M
    Therapie; 2007; 62(1):49-54. PubMed ID: 17374348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphosphonate osteonecrosis of the jaws in cancer patients.
    Kyrgidis A; Andreadis C
    Breast; 2009 Oct; 18(5):335. PubMed ID: 19783147
    [No Abstract]   [Full Text] [Related]  

  • 12. Osteonecrosis of the jaws in patients with a history of receiving bisphosphonate therapy: strategies for prevention and early recognition.
    Melo MD; Obeid G
    J Am Dent Assoc; 2005 Dec; 136(12):1675-81. PubMed ID: 16383049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bisphosphonates and osteonecrosis of the jaws in patients with myelomatosis].
    Neumann B; Gregersen H
    Ugeskr Laeger; 2006 May; 168(21):2078-9. PubMed ID: 16768928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Osteonecrosis of the jaws by long term therapy with bisphosphonates].
    Piesold JU; Al-Nawas B; Grötz KA
    Mund Kiefer Gesichtschir; 2006 Sep; 10(5):287-300. PubMed ID: 16960697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphosphonates: a potential threat to your patients.
    Dreiman BB
    J Indiana Dent Assoc; 2005-2006 Winter; 84(4):4-9. PubMed ID: 16605211
    [No Abstract]   [Full Text] [Related]  

  • 16. Osteonecrosis of the jaws and bisphosphonates. Report of three cases.
    Pastor-Zuazaga D; Garatea-Crelgo J; Martino-Gorbea R; Etayo-Pérez A; Sebastián-López C
    Med Oral Patol Oral Cir Bucal; 2006 Jan; 11(1):E76-9. PubMed ID: 16388300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteonecrosis of the jaws in patients treated with intravenous bisphosphonates (BRONJ): A concise update.
    Bagan J; Scully C; Sabater V; Jimenez Y
    Oral Oncol; 2009 Jul; 45(7):551-4. PubMed ID: 19251474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteonecrosis of the jaws in patients treated with bisphosphonates - histomorphologic analysis in comparison with infected osteoradionecrosis.
    Hansen T; Kunkel M; Weber A; James Kirkpatrick C
    J Oral Pathol Med; 2006 Mar; 35(3):155-60. PubMed ID: 16454811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between osteonecrosis of the jaws and chronic high-dosage intravenous bisphosphonates therapy.
    Graziani F; Cei S; La Ferla F; Cerri E; Itro A; Gabriele M
    J Craniofac Surg; 2006 Sep; 17(5):876-9. PubMed ID: 17003614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical experiences with bisphosphonate-associated osteonecrosis of the jaws: analysis of 21 cases.
    Junquera L; Gallego L; Cuesta P; Pelaz A; de Vicente JC
    Am J Otolaryngol; 2009; 30(6):390-5. PubMed ID: 19880027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.